Adipocyte lipid chaperone aP2 Is a secreted adipokine regulating hepatic glucose production

Cell Metabolism

Volumn 17, Issue 5, 2013, Pages 768-778

  Cao, Haiming ^a,b   Sekiya, Motohiro ^a   Ertunc, Meric Erikci ^a   Burak, M Furkan ^a   Mayers, Jared R ^a   White, Ariel ^a   Inouye, Karen ^a   Rickey, Lisa M ^a   Ercal, Baris C ^a   Furuhashi, Masato ^a,c   Tuncman, Gürol ^a   Hotamisligil, Gökhan S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CHAPERONE; PROTEIN AP2; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; IN VITRO STUDY; LIPOLYSIS; LIVER CELL; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION;

ADIPOCYTES; ADIPOKINES; ANIMALS; FATTY ACID-BINDING PROTEINS; GLUCOSE; HEPATOCYTES; LIPID METABOLISM; LIPIDS; LIPOLYSIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MOLECULAR CHAPERONES; OBESITY;

EID: 84877292005     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.04.012     Document Type: Article

References (36)

1. G. Boden Effects of free fatty acids on gluconeogenesis and glycogenolysis Life Sci. 72 2003 977 988
2. A. Cabré, N. Babio, I. Lázaro, M. Bulló, A. Garcia-Arellano, L. Masana, and J. Salas-Salvadó FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study Atherosclerosis 222 2012 229 234
3. G.F. Cahill Jr. Fuel metabolism in starvation Annu. Rev. Nutr. 26 2006 1 22
4. H. Cao, K. Maeda, C.Z. Gorgun, H.J. Kim, S.Y. Park, G.I. Shulman, J.K. Kim, and G.S. Hotamisligil Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice Diabetes 55 2006 1915 1922
5. H. Cao, K. Gerhold, J.R. Mayers, M.M. Wiest, S.M. Watkins, and G.S. Hotamisligil Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism Cell 134 2008 933 944
6. C.A. Chu, S.M. Sherck, K. Igawa, D.K. Sindelar, D.W. Neal, M. Emshwiller, and A.D. Cherrington Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs Am. J. Physiol. Endocrinol. Metab. 282 2002 E402 E411
7. E. Erbay, V.R. Babaev, J.R. Mayers, L. Makowski, K.N. Charles, M.E. Snitow, S. Fazio, M.M. Wiest, S.M. Watkins, M.F. Linton, and G.S. Hotamisligil Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis Nat. Med. 15 2009 1383 1391
8. C. Everett-Grueter, D.S. Edgerton, E.P. Donahue, S. Vaughan, C.A. Chu, D.K. Sindelar, and A.D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am. J. Physiol. Endocrinol. Metab. 291 2006 E449 E459
9. F. Féry, L. Plat, C. Melot, and E.O. Balasse Role of fat-derived substrates in the regulation of gluconeogenesis during fasting Am. J. Physiol. 270 1996 E822 E830
10. S. Fu, J. Fan, J. Blanco, A. Gimenez-Cassina, N.N. Danial, S.M. Watkins, and G.S. Hotamisligil Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting PLoS Genet. 8 2012 e1002902 10.1371/journal.pgen.1002902
11. M. Furuhashi, and G.S. Hotamisligil Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets Nat. Rev. Drug Discov. 7 2008 489 503
12. M. Furuhashi, G. Tuncman, C.Z. Görgün, L. Makowski, G. Atsumi, E. Vaillancourt, K. Kono, V.R. Babaev, S. Fazio, and M.F. Linton Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 Nature 447 2007 959 965
13. M. Furuhashi, R. Fucho, C.Z. Görgün, G. Tuncman, H. Cao, and G.S. Hotamisligil Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice J. Clin. Invest. 118 2008 2640 2650
14. M. Furuhashi, S. Ishimura, H. Ota, M. Hayashi, T. Nishitani, M. Tanaka, H. Yoshida, K. Shimamoto, G.S. Hotamisligil, and T. Miura Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease PLoS ONE 6 2011 e27356 10.1371/journal.pone.0027356
15. A.V. Hertzel, and D.A. Bernlohr The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function Trends Endocrinol. Metab. 11 2000 175 180
16. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
17. S.E. Karakas, R.U. Almario, and K. Kim Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers Metabolism 58 2009 1002 1007
18. S. Kralisch, and M. Fasshauer Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia 56 2013 10 21
19. T.K. Lam, A. Carpentier, G.F. Lewis, G. van de Werve, I.G. Fantus, and A. Giacca Mechanisms of the free fatty acid-induced increase in hepatic glucose production Am. J. Physiol. Endocrinol. Metab. 284 2003 E863 E873
20. H.V. Lin, and D. Accili Hormonal regulation of hepatic glucose production in health and disease Cell Metab. 14 2011 9 19
21. K. Maeda, H. Cao, K. Kono, C.Z. Gorgun, M. Furuhashi, K.T. Uysal, Q. Cao, G. Atsumi, H. Malone, and B. Krishnan Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes Cell Metab. 1 2005 107 119
22. L. Makowski, J.B. Boord, K. Maeda, V.R. Babaev, K.T. Uysal, M.A. Morgan, R.A. Parker, J. Suttles, S. Fazio, G.S. Hotamisligil, and M.F. Linton Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis Nat. Med. 7 2001 699 705
23. J.M. Olefsky, and J.J. Nolan Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms Am. J. Clin. Nutr. 61 4, Suppl 1995 980S 986S
24. W. Peeters, D.P. de Kleijn, A. Vink, S. van de Weg, A.H. Schoneveld, S.K. Sze, P.J. van der Spek, J.P. de Vries, F.L. Moll, and G. Pasterkamp Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events Eur. Heart J. 32 2011 1758 1768
25. E.D. Rosen, and B.M. Spiegelman Adipocytes as regulators of energy balance and glucose homeostasis Nature 444 2006 847 853
26. L. Rossetti, W. Chen, M. Hu, M. Hawkins, N. Barzilai, and S. Efrat Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele Am. J. Physiol. 273 1997 E743 E750
27. D.B. Savage, K.F. Petersen, and G.I. Shulman Disordered lipid metabolism and the pathogenesis of insulin resistance Physiol. Rev. 87 2007 507 520
28. M. Sekiya, N. Yahagi, T. Matsuzaka, Y. Takeuchi, Y. Nakagawa, H. Takahashi, H. Okazaki, Y. Iizuka, K. Ohashi, and T. Gotoda SREBP-1-independent regulation of lipogenic gene expression in adipocytes J. Lipid Res. 48 2007 1581 1591
29. Q. Tong, G. Dalgin, H. Xu, C.N. Ting, J.M. Leiden, and G.S. Hotamisligil Function of GATA transcription factors in preadipocyte-adipocyte transition Science 290 2000 134 138
30. A.W. Tso, A. Xu, P.C. Sham, N.M. Wat, Y. Wang, C.H. Fong, B.M. Cheung, E.D. Janus, and K.S. Lam Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort Diabetes Care 30 2007 2667 2672
31. R.H. Unger, and A.D. Cherrington Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover J. Clin. Invest. 122 2012 4 12
32. H. Waki, and P. Tontonoz Endocrine functions of adipose tissue Annu. Rev. Pathol. 2 2007 31 56
33. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796 1808
34. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, and H. Chen Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest. 112 2003 1821 1830
35. A. Xu, Y. Wang, J.Y. Xu, D. Stejskal, S. Tam, J. Zhang, N.M. Wat, W.K. Wong, and K.S. Lam Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome Clin. Chem. 52 2006 405 413
36. H.J. Yoo, S. Kim, M.S. Park, H.Y. Choi, S.J. Yang, J.A. Seo, S.G. Kim, N.H. Kim, S.H. Baik, D.S. Choi, and K.M. Choi Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography J. Clin. Endocrinol. Metab. 96 2011 E488 E492